YF-2
YF-2 is a highly selective, blood-brain-barrier permeable histone acetyltransferase activator, acetylates H3 in the hippocampus, with EC50s of 2.75 μM, 29.04 μM and 49.31 μM for CBP, PCAF, and GCN5, respectively, shows no effect on HDAC. Anti-cancer and anti-Alzheimer's disease[1].
Product Specifications
CAS Number
1311423-89-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/YF-2.html
Concentration
10mM
Purity
98.76
Solubility
DMSO : ≥ 125 mg/mL
Smiles
O=C(NC1=CC=C(Cl)C(C(F)(F)F)=C1)C2=C(OCC)C=CC=C2OCCN(C)C
Molecular Formula
C20H22ClF3N2O3
Molecular Weight
430.85
Precautions
H302, H315, H319, H335
References & Citations
[1]FENG, Yen, et al. HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF. WO 2011072243A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300; GCN5/PCAF
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GLCCI1, NT (GLCCI1, Glucocorticoid-induced transcript 1 protein) (MaxLight 550)
GLCCI1, NT (GLCCI1, Glucocorticoid-induced transcript 1 protein) (MaxLight 550)
